Global Endometriosis Market to Grow to $1.1 billion by 2017 Says Latest Report
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report.
By: Joe Walsh
The report estimates that the global endometriosis market was valued at $785m in 2009 and will grow at a CAGR of 4.3% to reach $1.1 billion by 2017. This modest growth forecast is primarily attributed to a weak pipeline landscape. The existing market is weak due to a lack of diagnostic techniques, disease awareness and the poor safety and efficacy profiles of the existing therapies. There is a high unmet need which is largely driven by the availability of drugs that are moderately successful in terms of safety and efficacy. The endometriosis market is primarily formed of generic and off-label drugs and has very few approved drugs which fall in the major therapeutic categories such as NSAIDs, oral contraceptives, GnRH agonists and progestins.
The report “Endometriosis:
Reportbuyer Product Code: GDA00789
Report Buyer http://www.reportbuyer.com/
# # #
Report Buyer is a UK-based independent online store supplying business information on major industry sectors. These include the Automotive Industry, Banking & Finance, Energy & Utilities, Food & Drink, Telecoms and Pharma & Healthcare.